sellWeak cluster of 3
Peter Soparkar sold $5,920 of ADVM
CHIEF OPERATING OFFICER at Adverum Biotechnologies, Inc.. 2,960 shares at an average of $2.00, traded May 15, 2025, filed May 16, 2025.
Warning score
35Value
$5,920
2,960 shares
Holdings after
39,154
-7% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +20RoleCOO
- 0Trade size$6k at market
- 0Share of holdings soldSold 7.0% of holdings
- +15Cluster3 insiders selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001415889-25-013446, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| May 15, 2025 | SOpen-market sale Common Stock | -2,960 | $2.00 | $5,920 | 39,154 | May 16, 2025 |
Related signals
Other insiders at Adverum Biotechnologies, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 62Notable | Adverum Biotechnologies, Inc. | Laurent Fischer CEO, PRESIDENT AND DIRECTOR | $554k 128,699 shares | +177% | |
| 50Moderate | Adverum Biotechnologies, Inc. | Peter Soparkar CHIEF OPERATING OFFICER | $211k 50,000 shares | +166% | |
| 42Moderate | ADVMsell Adverum Biotechnologies, Inc. | Braden Michael Leonard owner | $2.2M 524,560 shares | -21% | |
| 42Moderate | ADVMsell Adverum Biotechnologies, Inc. | Braden Michael Leonard owner | $2.4M 574,886 shares | -19% | |
| 40Moderate | Adverum Biotechnologies, Inc. | Laurent Fischer CEO, PRESIDENT AND DIRECTOR | $18k 9,126 shares | -9% | |
| 30Weak | Adverum Biotechnologies, Inc. | Setareh Seyedkazemi CHIEF DEVELOPMENT OFFICER | $1,848 924 shares | -6% | |
| 30Weak | ADVMbuy Adverum Biotechnologies, Inc. | Braden Michael Leonard owner | $189k 37,000 shares | +35% | |
| 30Weak | ADVMbuy Adverum Biotechnologies, Inc. | Braden Michael Leonard owner | $189k 37,000 shares | +35% | |
| 40Moderate | ADVMbuy Adverum Biotechnologies, Inc. | Braden Michael Leonard owner | $1.0M 350,000 shares | +13% | |
| 23Weak | ADVMbuy Adverum Biotechnologies, Inc. | Braden Michael Leonard owner | $147k 34,775 shares | +1% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.